Aktien aus dem Gesundheitswesen
| # | Name | Preis | 24h % | 7d % | 1M % | 1J % | Marktkapitalisierung | Letzte 7 Tage | |
|---|---|---|---|---|---|---|---|---|---|
| 121 | ACLX Arcellx, Inc. Common Stock | 114.9850 USD | +0.08% | +0.17% | +0.51% | +35.17% | 6.72 B USD | ||
| 122 | PTGX Protagonist Therapeutics, Inc | 105.0650 USD | +0.33% | +2.91% | +12.63% | +39.84% | 6.70 B USD | ||
| 123 | BLTE Belite Bio, Inc American Depositary Shares | 168.76 USD | -1.84% | -6.03% | +2.84% | +192.02% | 6.64 B USD | ||
| 124 | CNTA Centessa Pharmaceuticals plc American Depositary Shares | 39.6050 USD | +0.04% | +0.19% | +49.51% | +61.52% | 6.12 B USD | ||
| 125 | PTCT PTC Therapeutics, Inc. | 73.63 USD | +0.85% | +3.30% | +13.66% | +58.58% | 6.09 B USD | ||
| 126 | TERN Terns Pharmaceuticals, Inc. Common Stock | 52.71 USD | +0.06% | +0.09% | +11.44% | +2142.98% | 6.08 B USD | ||
| 127 | BRKR Bruker Corporation | 39.48 USD | -1.05% | +4.67% | +16.12% | +1.75% | 6.01 B USD | ||
| 128 | CELC Celcuity Inc. Common Stock | 123.34 USD | +2.06% | +5.60% | +5.31% | +1132.17% | 5.96 B USD | ||
| 129 | RYTM Rhythm Pharmaceuticals, Inc. Common Stock | 87.8100 USD | +0.61% | +2.50% | -0.84% | -20.40% | 6.00 B USD | ||
| 130 | BLCO Bausch + Lomb Corporation | 16.8450 USD | +0.87% | +2.46% | +2.90% | +9.24% | 5.97 B USD | ||
| 131 | COGT Cogent Biosciences, Inc. Common Stock | 36.3300 USD | -0.44% | -1.68% | -1.25% | +131.84% | 5.90 B USD | ||
| 132 | MIRM Mirum Pharmaceuticals, Inc. Common Stock | 96.0300 USD | -0.90% | -1.96% | +5.81% | +36.93% | 5.79 B USD | ||
| 133 | KNSA Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares | 45.9100 USD | -2.15% | -2.38% | +0.35% | +15.80% | 5.70 B USD | ||
| 134 | SRRK Scholar Rock Holding Corporation Common Stock | 49.2675 USD | -0.57% | -1.45% | +22.34% | +64.12% | 5.66 B USD | ||
| 135 | ERAS Erasca, Inc. Common Stock | 18.20 USD | +1.96% | +7.50% | +28.62% | +1442.37% | 5.66 B USD | ||
| 136 | TFX Teleflex Incorporated | 126.05 USD | +0.50% | +6.40% | +16.06% | -1.59% | 5.57 B USD | ||
| 137 | IMVT Immunovant, Inc. Common Stock | 27.4400 USD | +3.35% | +10.96% | +11.32% | +42.84% | 5.58 B USD | ||
| 138 | ALKS Alkermes Inc. plc | 33.22 USD | -1.92% | -5.09% | +18.81% | +20.67% | 5.54 B USD | ||
| 139 | TGTX TG Therapeutics, Inc. | 34.54 USD | -0.06% | +0.96% | +22.48% | -10.89% | 5.52 B USD | ||
| 140 | CRSP CRISPR Therapeutics AG | 56.76 USD | -0.18% | +10.71% | +14.67% | +48.39% | 5.45 B USD |
Nachrichten Aktien aus dem Gesundheitswesen
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.15%
Aktie von Taysha Gene Therapies klettert auf neues 52-Wochen-Hoch
Recursion-CEO erläutert KI-Strategie zur Beschleunigung der Medikamentenentwicklung
Travere Therapeutics: Re-Rating Potential As Filspari Wins Full Approval (NASDAQ:TVTX)
Will Breyanzi's Strong Uptake Help BMY Offset Generic Competition?
ADMA Crashes 42.5% YTD: Right Time to Buy the Stock?
Turbine Season for Tech: John Rowland on the Next Era of AI Data Center Investments
Gainers Aktien aus dem Gesundheitswesen
IMMP Immutep Limited American Depositary Shares | 0.54 | +74.19% |
CUE Cue Biopharma, Inc. | 0.72 | +63.64% |
NIVFW NewGenIvf Group Limited Class A ordinary shares | 0.0194 | +45.86% |
CDTTW CDT Equity Inc. Common Stock | 0.0085 | +41.67% |
NOTV Inotiv, Inc. Common Stock | 0.35 | +40.00% |
NXGL NexGel, Inc Common Stock | 0.76 | +28.81% |
PDSB PDS Biotechnology Corporation Common Stock | 1.36 | +28.30% |
TSHA Taysha Gene Therapies, Inc. Common Stock | 5.97 | +26.75% |
Losers Aktien aus dem Gesundheitswesen
WORX SC WORX Corp | 1.06 | -30.72% |
CMND Clearmind Medicine Inc. Common Shares | 0.65 | -28.57% |
BEAT Heartbeam, Inc. Common Stock | 0.89 | -25.83% |
TALKW Talkspace, Inc. Common Stock | 0.0016 | -23.81% |
CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.0796 | -20.32% |
JSPRW Jasper Therapeutics, Inc. Common Stock | 0.0166 | -20.19% |
TOIIW The Oncology Institute, Inc. Common Stock | 0.0399 | -18.40% |
ONCO Onconetix, Inc. Common Stock | 0.7601 | -16.47% |